loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Bexagliflozin, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Bexagliflozin

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Forms

    PATENTS

    DIGITAL CONTENT

    PharmaCompass

    Biopharma Group offers CDMO services with expertise in contract R&D for dried products & liquid formulations.

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    2D Structure
    1. Also known as: 1118567-05-7, Egt1442, Egt-1442, Thr-1442, Bexagliflozin [usan], Egt0001442
    Molecular Formula
    C24H29ClO7
    Molecular Weight
    464.9  g/mol
    InChI Key
    BTCRKOKVYTVOLU-SJSRKZJXSA-N
    FDA UNII
    EY00JF42FV
    Bexagliflozin is under investigation for the treatment of Type 2 Diabetes Mellitus. Bexagliflozin has been investigated for the treatment of Diabetes Mellitus and Type2 Diabetes Mellitus.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-(2-cyclopropyloxyethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
    2.1.2 InChI
    InChI=1S/C24H29ClO7/c25-19-8-3-15(24-23(29)22(28)21(27)20(13-26)32-24)12-16(19)11-14-1-4-17(5-2-14)30-9-10-31-18-6-7-18/h1-5,8,12,18,20-24,26-29H,6-7,9-11,13H2/t20-,21-,22+,23-,24+/m1/s1
    2.1.3 InChI Key
    BTCRKOKVYTVOLU-SJSRKZJXSA-N
    2.1.4 Canonical SMILES
    C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl
    2.1.5 Isomeric SMILES
    C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl
    2.2 Other Identifiers
    2.2.1 UNII
    EY00JF42FV
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-(2-cyclopropoxyethoxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol

    2.3.2 Depositor-Supplied Synonyms

    1. 1118567-05-7

    2. Egt1442

    3. Egt-1442

    4. Thr-1442

    5. Bexagliflozin [usan]

    6. Egt0001442

    7. Ey00jf42fv

    8. (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-(2-cyclopropoxyethoxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol

    9. Chembl1808388

    10. Thr1442

    11. Bexagliflozin (usan)

    12. Egt-0001442

    13. (2s,3r,4r,5s,6r)-2-(4-chloro-3-((4-(2-(cyclopropyloxy)ethoxy)phenyl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol

    14. (2s,3r,4r,5s,6r)-2-[4-chloro-3-[[4-(2-cyclopropyloxyethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol

    15. D-glucitol, 1,5-anhydro-1-c-(4-chloro-3-((4-(2-(cyclopropyloxy)ethoxy)phenyl)methyl)phenyl)-, (1s)-

    16. Unii-ey00jf42fv

    17. Egt1442; Bexagliflozin

    18. Bexagliflozin [inn]

    19. Schembl302200

    20. Bexagliflozin [who-dd]

    21. Ex-a2332

    22. Bdbm50349249

    23. Zinc59047505

    24. Bexagliflozin(thr1442egt1442)

    25. Cs-5702

    26. Db12236

    27. (1s)-1,5-anhydro-1-c-[4-chloro-3-[[4-[2-(cyclopropyloxy)ethoxy]phenyl]methyl]phenyl]-d-glucitol

    28. Ac-33643

    29. As-55919

    30. Hy-17604

    31. C71393

    32. D10865

    33. J-500393

    34. Q27277423

    2.4 Create Date
    2009-03-30
    3 Chemical and Physical Properties
    Molecular Weight 464.9 g/mol
    Molecular Formula C24H29ClO7
    XLogP32.4
    Hydrogen Bond Donor Count4
    Hydrogen Bond Acceptor Count7
    Rotatable Bond Count9
    Exact Mass464.1601810 g/mol
    Monoisotopic Mass464.1601810 g/mol
    Topological Polar Surface Area109 Ų
    Heavy Atom Count32
    Formal Charge0
    Complexity569
    Isotope Atom Count0
    Defined Atom Stereocenter Count5
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of type II diabetes mellitus

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Hypoglycemic Agents

    Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)

    Post Enquiry
    POST ENQUIRY